Location History:
- Gujarat, IN (2018)
- Sanand Ahmedabad, IN (2020 - 2021)
Company Filing History:
Years Active: 2018-2021
Title: The Innovative Journey of Himanshu Gadgil
Introduction
Himanshu Gadgil is an accomplished inventor based in Sanand, Ahmedabad, India. With a remarkable track record of three patents, Gadgil has made significant contributions to the pharmaceutical industry. His work primarily revolves around developing novel compositions that enhance the efficacy and stability of therapeutic agents.
Latest Patents
Gadgil's latest innovations include a groundbreaking lyophilized pharmaceutical composition of Fc-peptide fusion protein. This novel and thermostable formulation of Romiplostim incorporates essential components such as buffer, bulking agents, stabilizers, and surfactants, optimized for a pH range of 4.0-6.0. Additionally, he has developed a liquid pharmaceutical composition of adalimumab, which features an anti-TNFα antibody combined with a buffer, stabilizer, and surfactant, enhancing its effectiveness and usability.
Career Highlights
Currently, Himanshu Gadgil is associated with Intas Pharmaceuticals Limited, a prominent player in the pharmaceutical sector. His work at Intas involves extensive research and development, focused on innovative solutions that address pressing healthcare needs. His contributions stand as a testament to his commitment to advancing therapeutic technologies.
Collaborations
Gadgil collaborates with notable professionals in his field, including coworkers Chandresh Chhatbar and Vijaykant Pandey. Together, they refine and enhance their projects, ensuring that their inventions provide tangible benefits in medical applications.
Conclusion
Himanshu Gadgil exemplifies innovation in the pharmaceutical industry through his patent achievements and his role at Intas Pharmaceuticals Limited. His ongoing contributions continue to shape the landscape of healthcare, marking him as a notable inventor in his field.